Ginger and cancer: anticancer properties and dietary prevention

📌 In summary
Ginger possesses documented anti-cancer properties in laboratory settings: induction of apoptosis in cancer cells, inhibition of tumor angiogenesis, and anti-inflammatory-science-utilisation">anti-inflammatory effects. Human studies are limited. Ginger is not a treatment for cancer — it is a promising preventive food.

Ginger and cancer: what the science really says

⚠️ Important: Ginger is not a cancer treatment. This article presents current scientific data on the potential anti-cancer properties of ginger in the context of dietary prevention. If you have been diagnosed with cancer, it is essential to consult your oncologist.

Ginger's anti-cancer mechanisms (in vitro studies)

Induction of apoptosis (programmed cell death)

Gingerols and shogaols induce apoptosis in numerous cultured cancer cell lines: colorectal, gastric, lung, breast, ovarian, and prostate cancers. The mechanism involves the activation of caspases and the regulation of Bcl-2/Bax proteins. These effects are documented in hundreds of in vitro studies published in journals such as Cancer Letters, Oncogene, and Journal of Molecular Medicine.

Inhibition of tumor angiogenesis

Tumors create new blood vessels (angiogenesis) to nourish themselves. [6]-gingerol inhibits VEGF (Vascular Endothelial Growth Factor) — the main factor in tumor angiogenesis — thereby reducing nutrient supply to tumors.

Inhibition of metastasis

Animal studies show that ginger inhibits cell migration and invasion — two critical steps in metastasis formation. The mechanism involves the inhibition of MMP-2 metalloproteinase and the NF-κB factor.

Anti-inflammatory: reduction of a major risk factor

Chronic inflammation is an established risk factor for many cancers (colorectal, gastric, liver-protection-hepatique-nash">hepatic, pancreatic). By inhibiting COX-2 and NF-κB, ginger reduces chronic inflammation — a documented preventive mechanism.

Epidemiological and clinical studies (current limitations)

Most of the evidence comes from in vitro studies (cultured cells) or animal studies. Human clinical studies are rare and small-scale:

  • A pilot study (National Cancer Institute, 2011) showed that 2g of ginger per day for 28 days reduced inflammatory markers in the colon (PGE2) in people at risk of colorectal cancer — suggesting preventive potential.
  • Observational studies in Asia (high ginger consumption) show associations with a reduced incidence of certain gastric cancers.

Current scientific conclusion: promising but insufficient for clinical recommendations. Large-scale randomized trials are needed.

Ginger as a preventive food: the scientific position

Integrating ginger into a balanced diet is part of a global preventive approach, along with fruits, vegetables, fiber, and physical activity. It is not a "cancer cure" — it is a functional food with bioactive properties relevant for primary prevention.

INTI and preventive health

INTI Essence combines organic ginger from Belgium (gingerols, shogaols) and turmeric-poivre-noir-synergie-bienfaits">turmeric (curcumin — one of the most studied phytocompounds in preventive oncology). No added sugar, no preservatives. Available on inti-drink.com.

Frequently Asked Questions

Can ginger prevent cancer?

In vitro and animal data are promising (apoptosis induction, angiogenesis inhibition). In humans, a pilot study showed a reduction in inflammatory markers in the colon. Ginger is part of a comprehensive preventive diet, but it is not a treatment or a guaranteed prevention.

Does ginger help during chemotherapy?

Yes, for bloating-remede-naturel-2026">nausea. Several meta-analyses confirm the effectiveness of ginger in reducing chemotherapy-induced nausea. Consult your oncologist before any supplementation during treatment.

Ginger or turmeric for cancer?

Both have documented in vitro anti-cancer properties. Curcumin may be better studied in oncology, but ginger surpasses it in other aspects (chemo nausea, systemic anti-inflammatory). INTI combines both.

Sources: Cancer Letters (2014, 2018); Journal of Molecular Medicine (2016); National Cancer Institute Study (2011); Oncogene (2019); British Journal of Cancer (2015).

Related articles

To learn more, also read:

Back to blog